Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of Checkpoint Inhibitor-related Pneumonitis

NCT05280873 is registered in ClinicalTrials.gov with Zhou Chengzhi as lead sponsor.

NCT NCT05280873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05280873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of Checkpoint Inhibitor-related Pneumonitis
Lead sponsor
Zhou Chengzhi
Phase
Phase 1
Overall status
Unknown status
Start date
October 10, 2021
Completion date
October 20, 2024
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor, pneumonitis